In this Phase II SBIR/STTR project, our Specific Aim will be to determine if the use of
CBT4CBT-Buprenorphine leads to clinically significant improved outcomes and increased
retention for buprenorphine maintenance patients in a larger and diverse population of
individuals seeking buprenorphine treatment in primary care (N=100).
Phase:
Phase 1/Phase 2
Details
Lead Sponsor:
CBT4CBT, LLC
Treatments:
Buprenorphine Buprenorphine, Naloxone Drug Combination Naloxone